Product Details
Detection kit for Monkeypox virus (PCR- Fluorescence Probing)
Intended Use
Detection kit for Monkeypox virus is designed to detect DNA from
Monkeypox virus in specimens such as serum or plasma,
vesicular or pustular lesion fluid collected from individuals.
Monkeypox virus ( MPV) is a double- stranded DNA, zoonotic virus
and a species of the genus Orthopox virus in the family Poxviridae,
and causes a human disease that resembles smallpox.
Positive test results are indicative of the presence of Monkeypox
virus DNA; whereas clinical correlation with patient history and
other
diagnostic information is necessary for the determination of
patient infection status. Positive results from this test do not
rule out bacterial
infection or co- infection with other viruses.
Negative test results from the test do not completely preclude
Monkeypox virus infection and should not be used as the sole basis
for
patient management decisions. Negative results must be used in
combination with clinical observations, patient history, and
epidemiological information for a medical decision.
Experimental operators should have received professional training
in gene amplification or molecular biology method testing, and have
relevant experimental operating qualifications. The laboratory
should have reasonable biological safety precautions and protective
procedures.
Storage Conditions and Validity
This kit shall be stored at the temperature - 2 0 ± 5 ℃ in dark and
avoid repeated freezing and thawing ( if freezing and thawing , must not
exceed
4 times), with a validity period of 12 months . It can be stored at
2~8 ℃ after opening the cover, with a validity period of 30 days .
The kit shall be transported in an ice box .
Test Method
1. Nucleic acid extraction
2. PCR reagent preparation
3. Add samples
4. PCR amplification
5. QC standard
6. Result interpretation
Company Profile
Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan
District, Shenzhen, P.R. China. is a diagnostics company focused on
the development and manufacture of IVD tests at the Point-of-Care
with highly innovative proprietary technology.
We focused on the emerging markets of in vitro pathological
diagnosis and immunodiagnosis. We developed, manufactured and
successfully launched the in vitro immunodiagnosis platform for
cancer and the POCT for infectious, genetic and chronic diseases.
<span style="color: rgb(33, 33, 33); text-transform: none;
text-indent: 0px; letter-spacing: normal;" initial;"="" initial;=""
0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;=""
!important;="" inline="" none;="" 600;="" 14px;="" sans-serif;=""
arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",=""
hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,=""
freesans,="" yahei",="" "microsoft="" helvetica,="" grande",=""
"lucida="" ui",="" segoe="">At Kissh we work every day to shape
the future of in-vitro diagnostic testing. And our people are our
best asset, the reason for our track record and our strength while
we are moving forward. We live by our fundamental values and
incorporate them in everything that we do. Our best asset is ‘Step
Forward Every Second’